Search

Author/Creator Gobom, Johan

1. [P2–246]: NOVEL CSF FRAGMENTS OF TAU: CANDIDATE BIOMARKERS OF ALZHEIMER's DISEASE AND TAUOPATHIES. (1st July 2017)

Authors:
Höglund, Kina; Cicognola, Claudia; Portelius, Erik; Brinkmalm, Gunnar; Zheng, Zhentao; Hansson, Oskar; Zetterberg, Henrik; Ye, Keqiang; Blennow, Kaj; Gobom, Johan
Journal:
Alzheimer's & dementia
Issue:
Volume 13:Supplement 7S(2017)Part 14
Page Start:
P706
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. [P3–075]: PLEIOTROPHIN, A NEW BIOMARKER FOR AD, IDENTIFIED USING A NOVEL STRATEGY IN CLINICAL PROTEOMICS. (1st July 2017)

Authors:
Skillback, Tobias; Mattsson, Niklas; Hansson, Karl; Mirgorodskaya, Ekaterina; van der Flier, Wiesje M.; Scheltens, Philip; Duits, Floor; Hansson, Oskar; Teunissen, Charlotte E.; Blennow, Kaj; Zetterberg, Henrik; Gobom, Johan
Journal:
Alzheimer's & dementia
Issue:
Volume 13:Supplement 7S(2017)Part 20
Page Start:
P960
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. [P4–467]: LUMIPULSE® G TOTAL TAU: KEY PERFORMANCES OF A FULLY AUTOMATED CHEMILUMINESCENT IMMUNOASSAY. (1st July 2017)

Authors:
Vandijck, Manu; Dauwe, Martine; Huyck, Els; Le Bastard, Nathalie; Lawson, John; Traynham, Christopher; Vucetic, Zivjena; Gobom, Johan; Blennow, Kaj; Jannes, Geert; Kostanjevecki, Vesna
Journal:
Alzheimer's & dementia
Issue:
Volume 13:Supplement 7S(2017)Part 31
Page Start:
P1512
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. A novel antibody‐free mass spectrometry panel of CSF biomarkers for synaptic dysfunction. (31st December 2021)

Authors:
Nilsson, Johanna; Cousins, Katheryn A.Q.; Gobom, Johan; Portelius, Erik; Chen‐Plotkin, Alice; Shaw, Les M.; Grossman, Murray; Trojanowski, John Q.; Zetterberg, Henrik; Blennow, Kaj; Brinkmalm, Ann
Journal:
Alzheimer's & dementia
Issue:
Volume 17(2021)Supplement 5
Page Start:
n/a
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. A novel proteomics assay allows parallel quantitation of a panel of synaptic proteins in human cerebrospinal fluid: Biomarkers (non‐neuroimaging) / novel biomarkers. (7th December 2020)

Authors:
Nilsson, Johanna; Gobom, Johan; Brinkmalm, Gunnar; Zetterberg, Henrik; Brinkmalm, Ann; Blennow, Kaj
Journal:
Alzheimer's & dementia
Issue:
Volume 16(2020)Supplement 4
Page Start:
n/a
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. A novel quantification-driven proteomic strategy identifies an endogenous peptide of pleiotrophin as a new biomarker of Alzheimer's disease. Issue 1 (December 2017)

Authors:
Skillbäck, Tobias; Mattsson, Niklas; Hansson, Karl; Mirgorodskaya, Ekaterina; Dahlén, Rahil; Flier, Wiesje; Scheltens, Philip; Duits, Floor; Hansson, Oskar; Teunissen, Charlotte; Blennow, Kaj; Zetterberg, Henrik; Gobom, Johan
Journal:
Scientific reports
Issue:
Volume 7:Issue 1(2017)
Page Start:
1
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. A single dose of the γ-secretase inhibitor semagacestat alters the cerebrospinal fluid peptidome in humans. Issue 1 (December 2016)

Authors:
Hölttä, Mikko; Dean, Robert; Siemers, Eric; Mawuenyega, Kwasi; Sigurdson, Wendy; May, Patrick; Holtzman, David; Portelius, Erik; Zetterberg, Henrik; Bateman, Randall; Blennow, Kaj; Gobom, Johan
Journal:
Alzheimer's research & therapy
Issue:
Volume 8:Issue 1(2016)
Page Start:
1
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗